Base de données de recherche subventionnée canadienne sur la COVID-19

Queen's University

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 241 through 250 of 442 results (Download Results)

Show results per page

CO-Away: Implementation and Evaluation of Digital Health Solutions for Indigenous Self-Determination, Governance, and Data Sovereignty

Katapally, Tarun Reddy | Western University | Project Grant | $554,434

CIHR Ontario 2021

Mindfulness to Combat Health Care Worker Burnout during COVID-19: Evaluating a 4-week tailored program.

Ray, Mira A | Georgian College | Other | $75,000

CIHR Ontario 2020

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

Murty, Vijayakumar | University of Toronto | Operating Grant | $100,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Bell, John C | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

Peginterferon lambda to treat outpatients with COVID‑19 to prevent severe disease: Focus on variants of concern

Feld, Jordan J | University Health Network | Operating Grant | $994,420

CIHR Ontario 2021

COVID-19 Variant Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

Zhang, Haibo | Keenan Research Centre | Operating Grant | $50,000

CIHR Ontario 2021

Identifying strategies to (re)build trust in Canadian social institutions and increase public acceptance of COVID‑19 countermeasures

Meyer, Samantha | University of Waterloo | Operating Grant | $216,403

CIHR Ontario 2021

COVID-19 Variant Supplement – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Langlois, Marc-Andre | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

RESPECT-LTC

Hsu, Amy T | Bruyère Research Institute | Operating Grant | $150,000

CIHR Ontario 2020

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals

Côté, Marceline | University of Ottawa | Operating Grant | $50,000

CIHR Ontario 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

CO-Away: Implementation and Evaluation of Digital Health Solutions for Indigenous Self-Determination, Governance, and Data Sovereignty

Mindfulness to Combat Health Care Worker Burnout during COVID-19: Evaluating a 4-week tailored program.

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Peginterferon lambda to treat outpatients with COVID‑19 to prevent severe disease: Focus on variants of concern

COVID-19 Variant Supplement – Molecular and cellular therapies against COVID‑19 using angiotensin-converting enzyme 2 (ACE2)

Identifying strategies to (re)build trust in Canadian social institutions and increase public acceptance of COVID‑19 countermeasures

COVID-19 Variant Supplement – Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

RESPECT-LTC

COVID-19 Variant Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals